Hematology Analyzers and Reagents Market worth $3.13 Billion by 2019, According to a New Study on ASDReports

Thursday 22 May 2014, Amsterdam

The report “Hematology Analyzers & Reagents Market by Products (3-& 5- part hematology Analyzers, Point-of-Care, & Fully Automated), Consumables (Reagents & Stains), End Users (Research Institute, Hospital, & Clinical Testing Labs) - Global Forecasts to 2019”, now available on ASDReports, analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Europe, Asia-Pacific, and the Rest of the world (RoW).

This report studies the global hematology instruments and reagents market over the forecast period of 2014 to 2019. The market is expected to reach $3.13 billion by 2019, at CAGR of 5.2% from 2014 to 2019.

The global hematology market is divided into hematology products& services. Hematology products market has been segmented into instruments and consumables. Thehematology instruments market is further segmented into analyzers and slide strainers/makers. Whereas, the hematology consumables market has been classified into three major segments namely; regents, stains, and controls and calibrators. Furthermore, based on the end-users, the global hematology market has been segmented into commercial organizations, stand-alone hospitals, research institutes, and clinical testing labs.

A number of factors such as development of the high throughput hematology analyzers, integrationof basic flow-cytometry techniques in modern hematology analyzers, increasing adoption of automated hematology instruments by diagnostics laboratories, technological advancements, and developmentsin high sensitivity point-of-care (POC) hematology testing are propelling the growth of the global hematology analyzers and reagents market. On the other hand, slow adoption of the advanced hematology instruments in the emerging economies, hematology product recalls, and high cost of hematology analyzersare restricting the growth of the global hematology analyzers and reagents market.

As of 2014, North America holds the largest share of the global hematology analyzers and reagentsmarket, followed by Europe. However, the Asia-Pacific market is expected to grow at highest CAGR of ~9.4% from 2014 to 2019. A number of factors including developing healthcare infrastructure, large patient population, increasing funding/investment toward the development of hematology products, and growing focus of both international and domestic players on the Asia-Pacific countries are stimulating the growth of the hematology analyzers and reagents market in the Asia-Pacific region.

Sysmex Corporation (Japan), Beckman Coulter, Inc. (U.S.), Abbott Laboratories (U.S.), HORIBA, Ltd. (Japan), Siemens AG (Germany), Bio-Rad Laboratories, Inc. (U.S.), Boule Diagnostics AB (Sweden), Mindray Medical International Limited (China), Nihon Kohden Corporation (Japan), and Roche Diagnostics (Switzerland) are the key players operating in the global hematology analyzers and reagents market.